Developing and Marketing an FDA-Regulated Test
Exact Sciences overcame significant obstacles to bring cancer screening innovation to patients.
Read MorePosted by Elaine Sanchez Wilson | Feb 9, 2016 | Cancer, Microbiology Instruments, Molecular Diagnostics |
Exact Sciences overcame significant obstacles to bring cancer screening innovation to patients.
Read MorePosted by Elaine Sanchez Wilson | Feb 8, 2016 | Molecular Diagnostics |
Under a nonexclusive agreement, Henry Schein will market Cepheid’s GeneXpert system to its non-acute care laboratory customers in the United States.
Read MorePosted by Elaine Sanchez Wilson | Feb 2, 2016 | Uncategorized |
This month’s Product News includes focused gene expression panels, a cystatin C assay, a supply and procedure cart system, and a modular embedding system.
Read MorePosted by Elaine Sanchez Wilson | Feb 2, 2016 | Diabetes & Metabolic Diseases |
The assay was developed to offer confidence in patient results through standardization to the World Health Organization’s 3rd international standard for human thyroid stimulating hormone testing.
Read MorePosted by Elaine Sanchez Wilson | Feb 2, 2016 | Molecular Diagnostics |
The companies have partnered to develop a comprehensive next-generation sequencing workflow for single-cell analyses.
Read More